
Prime Medicine, Inc.
USD3.12
+0.07 (+2.30%)
CEO
Allan Reine
IPO Date
2022-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.08
Prev. Close
$3.05
Day Low
$2.93
Day High
$3.15
52W Low
$2.67
52W High
$6.94
Market Cap
$0.56B
Volume
3.75M
| 12 Aug 2025 |
| Citigroup |
| Neutral |
| Neutral |
| maintain |
| 8 Aug 2025 | Chardan Capital | Buy | Buy | maintain |
| 27 May 2025 | Citigroup | Buy | Neutral | downgrade |
| 20 May 2025 | JMP Securities | Market Outperform | Market Outperform | maintain |
| 20 May 2025 | JP Morgan | Overweight | Neutral | downgrade |
| 20 May 2025 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 19 May 2025 | Chardan Capital | Buy | Buy | maintain |